measure. To make the findings from the RCT more meaningful to scientists and practitioners, the number-needed-to-treat (NNT) in the target intervention (TAU + Stress management based on ACT) has to be reported. NNT refers to the "estimated number of patients who need to be treated with the new treatment rather the standard treatment for one additional patient to benefit". Introduction 2. MS p.5 Consider rewording the statement about mediators of therapeutic change from "reduced emotionally and cognitive avoidance" to "reduced emotional and cognitive avoidance" 3. The Theoretical justification section refers to concepts that may not be understandable to non-specialist readers (e.g. "…which explains why cognitive fusion and experiential avoidance are common phenomena causing suffering among individuals". Experiential avoidance is defined but the authors could consider providing a more plain English explanation of the concept of "cognitive fusion".
Methods and analysis 4. For the inclusion criteria, please specify whether the the HbA1c value needs to be exhibited for a specified time period 5. If available, some epidemiological data on the base rate of uncontrolled diabetes in the recruitment population would help contextualize the size of the sample 6. The description of the control group (MS p. 8) suggests that they are not truly a wait-list control (i.e. the controls do not progress to the intervention). Instead, they seem better characterized as a TAU control. If so, please clarify this and also indicate whether there will be any restrictions on TAU arm patients getting psychological therapy across the life of the trial. Thank you for the opportunity to review this interesting study protocol. Please, find below my overall evaluation.
The manuscript is well developed, the length is adequate, it includes recent and relevant studies in the theoretical framework, and the topic addressed is clearly presented to the reader. However, I have detected that there is one ongoing study (study protocol published in 2015: A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol. https://www.ncbi.nlm.nih.gov/pubmed/26594131), not cited by the authors, that is highly similar to the one presented here. In my opinion, the authors have a great opportunity to overcome the limitations of this ongoing RCT also conducted in Sweden (Uppsala University Hospital) by performing the following four changes in their protocol:
You mention the use of WL as control condition, but in fact you are using TAU as the control condition (p. 8; "Patients randomised to the control group will receive usual care"). In fact, your current study design is: TAU + Stress management based on ACT vs. TAU.
REPLY: The text in the abstract is revised: "This study will utilise a randomised controlled trial design" Moreover, I encourage the authors to add a new study arm including "psychological placebo" or another active psychological treatment, preferably one that has been established as "effective" for diabetes management (I think that the "gold-standard" would be classical CBT).
REPLY: We regard this as a very adequate point of view and will take it into consideration in future and larger scale studies when evaluating ACT as a method. For the time being we intend to test the method and hypothesis in a smaller sample with the reasonable resources we have access to. Unfortunately, there is a limited number of ACT-educated persons who are also involved in diabetes care.
(2) Sample size is far too small and I can see no reason why the authors want to recruit so few participants with Type I diabetes. Do a proper power analysis before starting the RCT and adjust the cell size for the attrition that may occur after 5 years of follow-up. You wanted to recruit and randomize 70 patients (35 per study arm) taking a 6-month follow-up into account, but you should recruit and randomise a larger sample size to have enough power for the final follow-up (5 years) analysis REPLY: Sample size is estimated to have sufficient statistical power (80%) to detect a specified effect 6 months after the intervention. This is the primary endpoint of the study and the power analysis is based on this. Comparisons after 6 months up to 5 years after the intervention are secondary endpoints. In addition, we plan to study differences between the groups by including all measurement points with Mixed Model Repeat Measurements. In these models, missing values and attrition will be compensated for by imputing data.
(3) Select ≥ 3 properly trained ACT therapists and randomize patients to therapist to allow an analysis of possible therapist effect on the primary and secondary outcomes.
REPLY: We also see this as an adequate point of view, however difficult to meet since there is a limited number of ACT-trained persons who are also involved in diabetes care. (4) Assess clinical significance of the improvement of the primary measure. To make the findings from the RCT more meaningful to scientists and practitioners, the number-needed-to-treat (NNT) in the target intervention (TAU + Stress management based on ACT) has to be reported. NNT refers to the "estimated number of patients who need to be treated with the new treatment rather the standard treatment for one additional patient to benefit".
REPLY: Text has been added to clarify this in the manuscript under "Analysis": Number needed to treat (NNT) to achieve clinically significant reduction in HbA1c will be computed, where clinically significant reduction in HbA1c will be defined by a reduction of HbA1c of 5 mmol/mol.
Reviewer: 2 Reviewer Name: Hamish McLeod Institution and Country: University of Glasgow, UK Please state any competing interests or state 'None declared': None Please leave your comments for the authors below Thank you for the opportunity to review this protocol. The authors are addressing an important issue that sits at the interface between mental and physical health. The following comments are provided in the hope that they will help improve any future revisions of this protocol. Abstract 1.
MS p.4 -consider changing "among poorly controlled adults living with type 1 diabetes" to "among adults living with poorly controlled type 1 diabetes" Introduction REPLY: Revised in the abstract as suggested.
2.
MS p.5 Consider rewording the statement about mediators of therapeutic change from "reduced emotionally and cognitive avoidance" to "reduced emotional and cognitive avoidance" REPLY: Revised in the introduction as suggested.
3.
The Theoretical justification section refers to concepts that may not be understandable to non-specialist readers (e.g. "…which explains why cognitive fusion and experiential avoidance are common phenomena causing suffering among individuals". Experiential avoidance is defined but the authors could consider providing a more plain English explanation of the concept of "cognitive fusion".
REPLY: This has been clarified under "Theoretical framework": Cognitive fusion is where we get entangled with our thoughts and pushed around by them rather than observing and see them for what they are -just products of our busy minds (Hayes, 1999) .
Methods and analysis

4.
For the inclusion criteria, please specify whether the the HbA1c value needs to be exhibited for a specified time period REPLY: This had been specified as suggested: HbA1c should be > 60 mmol/mol (reference value: < 42 mmol/mol) at baseline of measurement and at the last two visits according to the medical record.
5.
If available, some epidemiological data on the base rate of uncontrolled diabetes in the recruitment population would help contextualize the size of the sample REPLY: Added to the manuscript under "introduction": Currently Swedish registry data shows that approximately 22% of patients with type 1 diabetes reach treatment goals < 52 mmol/mol and that 20% are far above this level with measured HbA1c > 70 mmol/mol (NDR, 2016).
6.
The description of the control group (MS p. 8) suggests that they are not truly a waitlist control (i.e. the controls do not progress to the intervention). Instead, they seem better characterized as a TAU control. If so, please clarify this and also indicate whether there will be any restrictions on TAU arm patients getting psychological therapy across the life of the trial. REPLY: The study will utilize a randomised controlled trial design, which has been clarified under "methods analysis"
7.
No mention is made regarding fidelity checks and implementation quality assurance procedures for the experimental intervention. Will therapists be supervised? Is there any plan to ascertain whether the protocol is implemented as intended? Will there be any way of checking whether non-ACT consistent therapeutic ingredients have been introduced? REPLY: The licensed psychologist and the registered nurse have both been trained in ACT and they strictly follow an ACT manual developed by Fredrik Livheim, who is an internationally peer reviewed approved ACT trainer. Fidelity check will be performed by videotaping one session hold by the licensed psychologist and the registered nurse. Text on this procedure has been added to the manuscript under "intervention"".
8.
Does the analysis plan include any intention to examine mediators of therapeutic change?
REPLY: Text has been added to the manuscript under analysis: Self-care (SDSCA) and acceptance (AADQ and SAAQ) will be explored as possible mediators of the ACT intervention effect on HbA1c levels according to the approach described by Baron and Kenny (1986) . Formal test for mediation will be performed through a bootstrap approach as proposed by Preacher and Hayes (2004) . 
GENERAL COMMENTS
Thank you so much for the opportunity to review this manuscript again. As a researcher interested in third-wave CBT, it is a pleasure to see this RCT about this important topic. My comments/recommendations for minor revision are presented below: -Specify in the Abstract that your study design is: TAU + ACT vs. TAU -Mistake in the Abstract: "The questionnaires and will be administered..." -Strengths and limitation of this study: As indicated by Reviewer 2, consider changing "among poorly controlled adults living with type 1 diabetes" to "among adults living with poorly controlled type 1 diabetes" -Introduction: Comment this similar study protocol in your Introduction -https://www.ncbi.nlm.nih.gov/pubmed/26594131 -Methods and analysis: consider changing "SPRIRIT" to "SPIRIT" -Study design and setting: Your design is a two-arm randomised usual care controlled trial -TAU + ACT vs. TAU -HbA1c -consider changing "<" to ">" in the following statement: "...and 31-46 mmol/mol for those < 50 years"
REVIEWER
Hamish McLeod
University of Glasgow, UK REVIEW RETURNED 10-Jun-2018
GENERAL COMMENTS
The authors have clarified several points raised in the initial review and the manuscript is improved as a result of this. However, the consideration of process evaluation and implementation issues is still a relative weakness. I would encourage the authors to reconsider whether their methods for checking the fidelity of the intervention are rigorous enough to allow confidence that the intervention has been implemented as intended. As the authors will be aware, psychological interventions often encounter major problems when the transition is made from RCTs to everyday caregetting a good understanding of intervention fidelity at the RCT stage can help with later attempts to scale up if the treatment proves to be effective. Please leave your comments for the authors below Thank you so much for the opportunity to review this manuscript again. As a researcher interested in third-wave CBT, it is a pleasure to see this RCT about this important topic. My comments/recommendations for minor revision are presented below: -Specify in the Abstract that your study design is: TAU + ACT vs. TAU Respond: This has been clarified.
VERSION 2 -AUTHOR RESPONSE
-Mistake in the Abstract: "The questionnaires and will be administered..." Respond: This has been adjusted by deleting "and".
-Strengths and limitation of this study: As indicated by Reviewer 2, consider changing "among poorly controlled adults living with type 1 diabetes" to "among adults living with poorly controlled type 1 diabetes"
